Related Experiment Video
Updated: Jul 24, 2025

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
Published on: January 27, 2023
Use and Implications of Echocardiography in the Hemodynamic Assessment of Cardiogenic Shock
Pasquale S Simeoli1, Silvia Moscardelli1, Andrea Urbani1
1Division of Cardiology, Department of Health Sciences, San Paolo Hospital, University of Milan, Milan, Italy.
Insights
Cardiogenic shock (CS) management relies on hemodynamic assessment. Echocardiography offers a safe, noninvasive alternative to pulmonary artery catheterization for evaluating CS and guiding treatment.
Area of Science:
- Cardiology
- Critical Care Medicine
- Medical Imaging
Background:
- Cardiogenic shock (CS) is a severe condition with high mortality.
- Accurate hemodynamic assessment is crucial for CS diagnosis and management.
- Pulmonary artery catheterization, while standard, carries risks.
Purpose of the Study:
- To review the role of echocardiography in assessing cardiogenic shock.
- To highlight the benefits of noninvasive hemodynamic evaluation in CS.
- To explore the prognostic implications of combined cardiac and non-cardiac ultrasound findings in CS.
Main Methods:
- Review of current literature on echocardiography in cardiogenic shock.
- Analysis of transthoracic echocardiography's utility for multiparametric hemodynamic assessment.
- Emphasis on integrating cardiac and non-cardiac ultrasound data.
Main Results:
- Transthoracic echocardiography provides robust, noninvasive hemodynamic evaluation for CS.
- Ultrasound aids in defining CS etiology and guiding therapeutic interventions.
- Combined cardiac and non-cardiac ultrasound findings correlate with patient prognosis.
Conclusions:
- Echocardiography is a valuable tool in the management of cardiogenic shock.
- Noninvasive ultrasound assessment improves patient safety and treatment guidance.
- Integrated ultrasound approaches offer prognostic insights in CS.
Abstract:
Cardiogenic shock (CS) is a complex multisystem syndrome due to pump failure, associated with high mortality and morbidity. Its hemodynamic characterization is key to the diagnostic algorithm and management. Pulmonary artery catheterization is the gold standard for the left and right hemodynamic evaluation, but some concerns exist for invasivity and untoward mechanical and infective complications. Transthoracic echocardiography is a robust noninvasive diagnostic tool for hemodynamic multiparametric assessment that well applies to the management of CS. Its applications expand from etiology definition to the choice of therapeutic intervention and their monitoring. The present review aims at detailing the role of ultrasounds in CS emphasizing the clinical implications of combining cardiac and non-cardiac ultrasounds examinations that may correlate with prognosis.
More Related Videos
08:37Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Imaging Studies for Cardiovascular System II:Types of Echocardiography
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Assessing Blood pressure using a doppler ultrasound
Pre-Procedural Guidelines for Doppler Ultrasound Blood Pressure Assessment:
Preparation of Equipment:
Acute Coronary Syndrome III: Diagnostic Studies
Dysrhythmias V: Evaluating Dysrhythmias
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies